Glasgow Alcoholic Hepatitis Score (GAHS)

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

حداقل ۱ — حداکثر ۱۰۰ • واحد: ×10⁹/L

حداقل ۱ — حداکثر ۵۰ • واحد: mmol/L

حداقل ۰.۸ — حداکثر ۱۰ • واحد: ratio

حداقل ۱۰ — حداکثر ۱۰۰۰ • واحد: μmol/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
gahs score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk5–8
  • High Risk9–12
Direct Clinical Answer

The Glasgow Alcoholic Hepatitis Score (GAHS) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include age. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Prognostic score for mortality prediction in patients with alcoholic hepatitis using five clinical variables: age, white blood cell count, urea, prothrombin time ratio, and bilirubin. More accurate than the modified Discriminant Function for predicting 28-day mortality

Clinical Indication

The Glasgow Alcoholic Hepatitis Score (GAHS) is indicated for bedside clinical practice to support Prognostic score for mortality prediction in patients with alcoholic hepatitis using five clinical variables: age, white blood cell count, urea, prothrombin time ratio, and bilirubin. More accurate than the modified Discriminant Function for predicting 28-day mortality. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Consider contraindications to corticosteroids before treatment initiation.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Sensitivity: 81% (day 1), 93% (day 7); Specificity: 61% (day 1), 68% (day 7).

Formula & Variables:

Score = Age points + WBC points + Urea points + PT ratio points + Bilirubin points. Total range: 5-12 points. Cutoff: ≥9 indicates high mortality risk

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient age in years(years)
white_cell_countfloatYesWhite blood cell count(×10⁹/L)
ureafloatYesBlood urea nitrogen (BUN). Urea was chosen over creatinine as marker of renal function to avoid interference from hyperbilirubinaemia(mmol/L)
prothrombin_time_ratiofloatYesProthrombin time ratio (PT ratio) or INR. Reflects synthetic liver function and coagulopathy(ratio)
bilirubinfloatYesSerum total bilirubin level. Major marker of hepatic dysfunction in alcoholic hepatitis(μmol/L)

Score Interpretation & Guidance

RangeStageDescription
5–8Low RiskGood prognosis
9–12High RiskPoor prognosis

Evidence-Based References (EBM)

  • Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54(8):1174-1179. doi: 10.1136/gut.2004.050781.DOI: 10.1136/gut.2004.050781
  • Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45(6):1348-1354. doi: 10.1002/hep.21607.DOI: 10.1002/hep.21607
  • Forrest EH, Morris AJ, Stewart S, et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut. 2007;56(12):1743-1746. doi: 10.1136/gut.2006.099226.DOI: 10.1136/gut.2006.099226

Related calculators